Tracked deals
24
24 tracked deals across 2019-2026.
New York, New York, United States
New York–headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies. Formed through the spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division, with a focus on U.S. companies poised for sustainable growth, concentrated in Business Services and Healthcare Services.
Tracked deals
24
24 tracked deals across 2019-2026.
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Addon
14 addon · 9 recapitalization · 1 buyout
Last 7 years
Supporting Data
Showing the 12 most recent of 24 tracked deals for NMS Capital.
NMS Capital launched Asurgence Medical, creating a surgical suite maintenance, repair, and overhaul platform. The platform was formed through the recapitalization of ENDOCORP (with ENDOCORP continuing under its existing brand) and the concurrent acquisition of Medical Optics from Probo Medical, with both operating under Asurgence subsidiaries and existing leadership.
Surplus Solutions, a portfolio company of NMS Capital, acquired Boston Industries, a Walpole, Massachusetts-based specialist in technical repair and refurbishment of laboratory instruments. The acquisition expands Surplus Solutions’ in-house lab repair capabilities across areas such as flow cytometry, microscopy, and liquid handling. Terms were not disclosed.
NMS Capital portfolio company Flourish Research has partnered with ENCORE Research Group, a clinical research organization with eight locations across Northern Florida and more than 100 investigators. The transaction — the eleventh add-on to the Flourish platform since 2021 — expands Flourish's geographic footprint and therapeutic capabilities; terms were not disclosed.
Strive Medical, a portfolio company of NMS Capital, has acquired ProMed DME, a Stuart, Florida-based durable medical equipment provider specializing in diabetic continuous glucose monitoring (CGM) supplies as well as urology and wound care products. Strive will operate ProMed as a Diabetes Center of Excellence to expand its diabetic supplies offering, broaden commercial reach, and increase its patient census across urology and related product lines.
NMS Capital has partnered with the management of VONA Case Management in a recapitalization to support the company's growth and M&A initiatives. VONA, headquartered in Daphne, Alabama, provides medical case management services to self-insured employers, workers' compensation carriers, and TPAs across the U.S.; terms were not disclosed.
U.S. Foot & Ankle Specialists (USFAS), a portfolio company of NMS Capital, acquired multiple podiatry practices including Augusta Podiatric Medicine & Surgery and Center for Foot and Ankle Care, PC as part of a continued roll-up. The deal brings several single-location and small multi-location practices into USFAS’s platform to expand its Mid‑Atlantic footprint and consolidate operational, IT and administrative functions.
NMS Capital portfolio company U.S. Urology Partners has announced an affiliation with Urology of Indiana, expanding the U.S. Urology network into Indiana and bringing the platform to more than 150 providers across 40+ locations in four states. Terms were not disclosed; Urology of Indiana is a market-leading multi-specialty urology practice with roughly 40 physicians and 20 advanced practice providers and will operate as an affiliate of the U.S. Urology platform.
U.S. Foot & Ankle Specialists (USFAS), a portfolio company of NMS Capital, acquired Missouri Foot and Ankle (three clinics in Missouri) and Rock River Foot and Ankle Clinic PC (two clinics in Wisconsin). The transactions are add-on acquisitions that expand USFAS's clinical footprint in Missouri and Wisconsin and will integrate the practices into USFAS's administrative and clinical support platform.
U.S. Foot & Ankle Specialists (USFAS), a Rockville, Maryland-based podiatric practice platform backed by NMS Capital, acquired Delaware Foot and Ankle Group, which operates three offices across Delaware. The deal expands USFAS's Mid-Atlantic footprint and brings Delaware Foot and Ankle Group access to USFAS's administrative, revenue cycle, IT and clinical compliance resources.
NMS Capital has completed a recapitalization partnership with the management of LDR Site Services, an Atlanta-headquartered, asset-light provider of equipment rental and waste hauling solutions for site-based projects across the U.S. The investment will support growth initiatives including investments in operations, technology and sales and enable pursuit of strategic add-on acquisitions.
NMS Capital portfolio company Flourish Research partnered with Excel Medical Clinical Trials in a recapitalization. The Boca Raton, Florida-based clinical research site, founded by Dr. Seth Baum and focused on cardiology indications, will join Flourish's site network to expand the platform's geographic footprint and therapeutic capabilities; terms were not disclosed and management will remain in place.
NMS Capital formed a new platform, Flourish Research, and completed a recapitalization of Clinical Trials of Texas (CTT) in partnership with founder Kay Scroggins and company management. The deal makes CTT the inaugural partner in a buy-and-build strategy to create a nationwide network of clinical research sites; CTT is headquartered in San Antonio, Texas, operates a 20,000+ sq. ft. facility and has conducted over 1,000 trials across more than 15 therapeutic areas.
Turn tracked acquisition activity into an outreach-ready buyer list.